Provided by Tiger Trade Technology Pte. Ltd.

CALCIMEDICA

1.98
0.0000
Post-market: 2.030.0461+2.33%17:39 EDT
Volume:65.58K
Turnover:131.30K
Market Cap:13.52M
PE:-0.30
High:2.06
Open:2.00
Low:1.94
Close:1.98
52wk High:36.00
52wk Low:1.87
Shares:6.83M
Float Shares:3.96M
Volume Ratio:0.73
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6528
EPS(LYR):-9.8500
ROE:-365.70%
ROA:-63.58%
PB:2.45
PE(LYR):-0.20

Loading ...

CalciMedica Regains Nasdaq Compliance, Listing Status Stabilized

TIPRANKS
·
1 hour ago

CalciMedica - Regains NASDAQ Minimum Bid Price Compliance as of Sept 15, 2026 - SEC Filing

THOMSON REUTERS
·
1 hour ago

CalciMedica Regains NASDAQ Compliance After Shares Close Above $1 for 10 Straight Sessions

Reuters
·
1 hour ago

CalciMedica Addresses Nasdaq Equity Compliance Amid Bid-Price Risk

TIPRANKS
·
Sep 02

CalciMedica Implements 1-for-5 Reverse Stock Split to Address NASDAQ $1 Minimum Bid Rule

Reuters
·
Sep 02

NASDAQ Trade Halt Continues Halt News Pending at 08:59 Pm

Reuters
·
Aug 29

Calcimedica Inc trading halted, news pending

TIPRANKS
·
Aug 29

CalciMedica to effect 1-for-5 reverse stock split

TIPRANKS
·
Aug 27

CalciMedica Announces One-for-Five Reverse Stock Split

THOMSON REUTERS
·
Aug 27

CalciMedica Price Target Announced at $9.00/Share by Guggenheim

Dow Jones
·
Aug 20

CalciMedica Shareholders Approve 7.5 Million-Share Increase to Equity Incentive Plan

Reuters
·
Aug 20

CalciMedica initiated with a Buy at Guggenheim

TIPRANKS
·
Aug 20

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)

TIPRANKS
·
Aug 13

CalciMedica Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

CalciMedica Q2 EPS $(0.45) Misses $(0.28) Estimate

Benzinga Earnings
·
Aug 11

CalciMedica Q2 FY26 Net Loss Widens to $7.65 Million

Reuters
·
Aug 11

CalciMedica Q2 Basic EPS USD -0.45

THOMSON REUTERS
·
Aug 11

Press Release: CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates

Dow Jones
·
Aug 11

CalciMedica Inc Expected to Post a Loss of 28 Cents a Share - Earnings Preview

Reuters
·
Aug 08

CalciMedica announces FDA alignment on Phase 2b Auxora trial design

TIPRANKS
·
Jul 29